128 related articles for article (PubMed ID: 7583383)
1. Evans syndrome. Results of a pilot study utilizing a multiagent treatment protocol.
Scaradavou A; Bussel J
J Pediatr Hematol Oncol; 1995 Nov; 17(4):290-5. PubMed ID: 7583383
[TBL] [Abstract][Full Text] [Related]
2. Rituximab for immune cytopenia in adults: idiopathic thrombocytopenic purpura, autoimmune hemolytic anemia, and Evans syndrome.
Shanafelt TD; Madueme HL; Wolf RC; Tefferi A
Mayo Clin Proc; 2003 Nov; 78(11):1340-6. PubMed ID: 14601692
[TBL] [Abstract][Full Text] [Related]
3. The use of vinca alkaloids in preparation for splenectomy of corticosteroid refractory chronic immune thrombocytopenic purpura patients.
Szczepanik AB; Sikorska A; Slomkowski M; Konopka L
Int J Lab Hematol; 2007 Oct; 29(5):347-51. PubMed ID: 17824915
[TBL] [Abstract][Full Text] [Related]
4. [Evans' syndrome: a retrospective study from the ship (French Society of Pediatric Hematology and Immunology) (36 cases)].
Blouin P; Auvrignon A; Pagnier A; Thuret I; Antoni G; Bader-Meunier B; Le Deist F; Chastagner P; Aladjidi N; Pellier I; Bertrand Y; Behar C; Landmann-Parker J; Leverger G; Perel Y
Arch Pediatr; 2005 Nov; 12(11):1600-7. PubMed ID: 16185853
[TBL] [Abstract][Full Text] [Related]
5. Rituximab in auto-immune haemolytic anaemia and immune thrombocytopenic purpura: a Belgian retrospective multicentric study.
Dierickx D; Verhoef G; Van Hoof A; Mineur P; Roest A; Triffet A; Kentos A; Pierre P; Boulet D; Bries G; Lê PQ; Janssens A; Delannoy A
J Intern Med; 2009 Nov; 266(5):484-91. PubMed ID: 19549092
[TBL] [Abstract][Full Text] [Related]
6. Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura.
Braendstrup P; Bjerrum OW; Nielsen OJ; Jensen BA; Clausen NT; Hansen PB; Andersen I; Schmidt K; Andersen TM; Peterslund NA; Birgens HS; Plesner T; Pedersen BB; Hasselbalch HC
Am J Hematol; 2005 Apr; 78(4):275-80. PubMed ID: 15795920
[TBL] [Abstract][Full Text] [Related]
7. Intravenous immunoglobulin therapy of immune thrombocytopenia.
Mehta JB; Singhal SB; Mehta BC
J Assoc Physicians India; 1992 May; 40(5):340-2. PubMed ID: 1483999
[TBL] [Abstract][Full Text] [Related]
8. [Effective danazol therapy for a patient with Evans syndrome].
Koike M; Ishiyama T; Saito K; Osawa H; Hashimoto M; Wakabayashi Y; Tsuruoka N
Rinsho Ketsueki; 1993 Feb; 34(2):143-6. PubMed ID: 8492411
[TBL] [Abstract][Full Text] [Related]
9. [Effective cyclosporine therapy to resistant-Evans syndrome].
Tsudo M; Moriguchi T
Rinsho Ketsueki; 1996 Nov; 37(11):1289-92. PubMed ID: 8960663
[TBL] [Abstract][Full Text] [Related]
10. Treatment of idiopathic thrombocytopenic purpura (ITP) in patients with refractoriness to or with contraindication for corticosteroids and/or splenectomy with immunosuppressive therapy and danazol.
Schiavotto C; Castaman G; Rodeghiero F
Haematologica; 1993; 78(6 Suppl 2):29-34. PubMed ID: 8039755
[TBL] [Abstract][Full Text] [Related]
11. [The effectiveness of cyclosporin A in the treatment of autoimmune hemolytic anemia and Evans syndrome].
Liu H; Shao Z; Jing L
Zhonghua Xue Ye Xue Za Zhi; 2001 Nov; 22(11):581-3. PubMed ID: 11855146
[TBL] [Abstract][Full Text] [Related]
12. Treatment and outcome of autoimmune hematologic disease in common variable immunodeficiency (CVID).
Wang J; Cunningham-Rundles C
J Autoimmun; 2005 Aug; 25(1):57-62. PubMed ID: 15994061
[TBL] [Abstract][Full Text] [Related]
13. Treatment, outcome, and cost of care in children with idiopathic thrombocytopenic purpura.
Kumar M; Vik TA; Johnson CS; Southwood ME; Croop JM
Am J Hematol; 2005 Mar; 78(3):181-7. PubMed ID: 15726607
[TBL] [Abstract][Full Text] [Related]
14. [The combination therapy with vinca-alkaloid slow infusion and cholchicine was effective to refractory idiopathic thrombocytopenic purpura. The patient could receive femoral head replacement in safety].
Nezu M; Oh H; Cho R; Sato H; Ikegami T; Yokota A; Nakaseko C; Nishimura M; Matsuura Y; Morio S; Hiruma K; Nakamura H; Asai T
Rinsho Ketsueki; 1996 Feb; 37(2):158-60. PubMed ID: 8852035
[TBL] [Abstract][Full Text] [Related]
15. Overview of 321 patients with idiopathic thrombocytopenic purpura. Retrospective analysis of the clinical features and response to therapy.
Pamuk GE; Pamuk ON; Başlar Z; Ongören S; Soysal T; Ferhanoğlu B; Aydin Y; Ulkü B; Aktuğlu G; Akman N
Ann Hematol; 2002 Aug; 81(8):436-40. PubMed ID: 12224000
[TBL] [Abstract][Full Text] [Related]
16. [Efficacy of various treatments in the management of idiopathic thrombocytopenic purpura in the adult].
Llamas P; Busto MJ; Díez JL; Cabrera R; Regidor C; Forés R; Sanjuán I; Briz M; Fernández MN
Sangre (Barc); 1995 Jun; 40(3):181-5. PubMed ID: 7570269
[TBL] [Abstract][Full Text] [Related]
17. Clinical usefulness of vinca alkaloid slow infusion in the treatment of chronic refractory idiopathic thrombocytopenic purpura: a multicenter cooperative study.
Nomura T; Maekawa T; Uchino H; Miyazaki T; Miura Y; Abe T; Asano S; Kuriya S; Nagai K; Yawata Y
Nihon Ketsueki Gakkai Zasshi; 1990 Feb; 53(1):98-104. PubMed ID: 2184637
[TBL] [Abstract][Full Text] [Related]
18. Multiagent induction and maintenance therapy for patients with refractory immune thrombocytopenic purpura (ITP).
Boruchov DM; Gururangan S; Driscoll MC; Bussel JB
Blood; 2007 Nov; 110(10):3526-31. PubMed ID: 17698634
[TBL] [Abstract][Full Text] [Related]
19. Autoimmune hemolytic anemia and idiopathic thrombocytopenic purpura in pediatric solid organ transplant recipients, report of five cases and review of the literature.
Miloh T; Arnon R; Roman E; Hurlet A; Kerkar N; Wistinghausen B
Pediatr Transplant; 2011 Dec; 15(8):870-8. PubMed ID: 22112003
[TBL] [Abstract][Full Text] [Related]
20. Treatment of refractory Evans syndrome with alternate-day cyclosporine and prednisone.
Rackoff WR; Manno CS
Am J Pediatr Hematol Oncol; 1994 May; 16(2):156-9. PubMed ID: 8166369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
